1-5 of 5
David A Frank, MD PhD
Close
Sort by
Journal Articles

Targeting MET and FGFR in Relapsed or Refractory Acute Myeloid Leukemia: Preclinical, Clinical, and Correlative Studies

Jacqueline S Garcia, MD, Helen I. Gandler, Geoffrey Fell, MS, Ashlee J. Fiore, Donna S Neuberg, ScD, Adrienne Anderson, Kelsey O'Day, Marlise Luskin, MDMS, Martha Wadleigh, MD, Eric S. Winer, MD, Ilene Galinsky, Daniel J. DeAngelo, MD, David A. Frank, MD PhD, Richard M. Stone, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 2549.
https://doi.org/10.1182/blood-2019-126224
Published: 2019
Journal Articles

A Clinical Trial of the STAT3 Inhibitor Pyrimethamine in Chronic Lymphocytic Leukemia

Jennifer R. Brown, MD PhD, Sarah R. Walker, PhD, Lisa N. Heppler, Svitlana Tyekucheva, Erik Nelson, PhD, Josephine L. Klitgaard, MSc, PhD, Maria Nicolais, MD, Yasmin Kroll, Michael Xiang, MD PhD, Jennifer E. Yeh, MD PhD, Mousumi Chaudhury, Zachary T. Giaccone, Stacey Fernandes, Jeffrey G. Supko, PhD, Catherine J. Wu, MD, David A. Frank, MD PhD
Journal: Blood
Blood (2018) 132 (Supplement 1): 1855.
https://doi.org/10.1182/blood-2018-99-118921
Published: 2018
Journal Articles

FLT3 Splice Variant (FLT3Va) As a Potential Immunotherapeutic Target in Patients with Acute Myeloid Leukemia (AML)

Sophia Adamia, PhD, Jeffrey Nemeth, PhD, Shruti Bhatt, PhD, Sarah R Walker, Natalie I Voeks, William Lento, PhD, Ricardo M. Attar, Ilene Galinsky, MSN, ANPc, David A Frank, MD PhD, Martha Wadleigh, MD, Anthony Letai, MD PhD, David P. Steensma, MD, David M. Weinstock, MD, Daniel J. DeAngelo, MD PhD, David M. Dorfman, MD PhD, Richard M. Stone, MD, James D Griffin, MD
Journal: Blood
Blood (2016) 128 (22): 1681.
https://doi.org/10.1182/blood.V128.22.1681.1681
Published: 2016
Journal Articles

Targeting of MDS and AML Stem Cells Via Inhibition of STAT3 By Pyrimethamine

Aditi Shastri, MD, Carolina Schinke, MD, Asya Varshavsky Yanovsky, MD PhD, Tushar D. Bhagat, PhD, Orsolya Giricz, Laura Barreyro, M.Sc., Jacqueline Boultwood, PhD, Andrea Pellagati, Yiting Yu, PhD, Jennifer R. Brown, MD PhD, David A. Frank, MD PhD, Bhaskar Das, PhD, Suman Kambhampati, MD, Britta Will, PhD, Ulrich Steidl, MDPhD, Amit Verma, MD
Journal: Blood
Blood (2014) 124 (21): 3602.
https://doi.org/10.1182/blood.V124.21.3602.3602
Published: 2014
Journal Articles

Inhibition of Both Jak2 and STAT5 Enhances Toxicity to Myeloproliferative Cells.

Michal Bar-Natan, M.D, Erik A. Nelson, PhD, Sarah R. Walker, Ph.D., Rosemary Barrett, B.S., David A. Frank, MD, PhD
Journal: Blood
Blood (2009) 114 (22): 1905.
https://doi.org/10.1182/blood.V114.22.1905.1905
Published: 2009